CAS: 2170729-29-8
Ref: AN-AG01V487
| 1mg | 67.00 € | |
| 5mg | 127.00 € | |
| 10mg | 166.00 € | |
| 25mg | 192.00 € | |
| 50mg | 232.00 € | |
| 100mg | 522.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
AT-007
CAS:2170729-29-8
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia …
Formula:
C17H10F3N3O3S2
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
425.4
Ref: TM-T10393
| 1mg | 79.00 € | |
| 5mg | 153.00 € | |
| 10mg | 233.00 € | |
| 25mg | 433.00 € | |
| 50mg | 635.00 € | |
| 100mg | 907.00 € | |
| 1ml*10 (DMSO) | 167.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
![2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid](https://static.cymitquimica.com/products/10/thumb/F546907.jpg)
2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid
CAS:2170729-29-8
Purity:
98.0%
Molecular weight:
425.3999938964844
Ref: 10-F546907
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 29 May 2024
AT-007
CAS:2170729-29-8
AT-007 is a research tool to be used as an activator, ligand, or receptor. It …
Formula:
C17H10F3N3O3S2
Purity:
Min. 95%
Molecular weight:
425.4 g/mol
Ref: 3D-VLD72929
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
